Emergent BioSolutions Inc. (EBS)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$6.06
+2.56%
Mkt Cap $310.72M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (4 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+65.0%
Consensus $10.00 vs current $6.06